Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Wilms Tumor × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

X-Rays 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy 3 Nuclear Medicine Department, Hospital 3 Vincristine 2 Radiation 2 Doxorubicin 2 Dactinomycin 2 Carboplatin 2 Biopsy 2 ulixertinib 1 tipifarnib 1 thymoglobulin 1 tazemetostat 1 selpercatinib 1 sargramostim 1 pembrolizumab 1 palbociclib 1 olaparib 1 lorvotuzumab mertansine 1 larotrectinib 1 glutamic acid diethyl ester 1 etoposide phosphate 1 erdafitinib 1 cixutumumab 1 Vemurafenib 1 Surgical Procedures, Operative 1 Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡